|This article does not cite any references or sources. (September 2009)|
Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
Exisulind is a drug used to treat cancer. It acts by inhibiting the enzyme cyclic guanosine monophosphate phosphodiesterase. Trademark by OSI Pharmaceuticals is Aptosyn. NCBI PubChem ID 5472495. Also listed as Sulindac sulfone which is a metabolic product of Sulindac (see).
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|